Did you miss the CV Symposium March 2022? Do you want to (re)watch a talk from the webinar? Watch the talks from Dr Rani Khatib, Dr Yassir Javaid, Dr Jaimini Cegla and Dr Mike Fisher.
To ensure you do not miss our future events, please sign up for email updates
The continuing role of secondary care in lipid optimisation post-ACS
Dr Rani Khatib discusses the reasons why post-MI secondary prevention clinics should be established, explains the Leeds Cardiometabolic Medicines Optimisation Pathway and their Multidisciplinary Innovative Medicines Clinic for PCSK9i & Statin Intolerance, the benefits to patients and healthcare system, and the challenges to overcome.
Strengthening the interface between primary and secondary care
Dr Yassir Javaid discusses the interface between primary and secondary care, the tools that primary care have access to in order to identify and risk stratify patients who need referral to secondary care, what primary care need from secondary care and a post-ACS checklist to be included within the discharge summary.
What's the future of secondary care lipid services?
Dr Jaimini Cegla discusses what the future of secondary care lipid services looks like, covering management of patients with premature cardiovascular disease, residual risk, other dyslipidaemias, specialist treatments and rare dyslipidaemia's.
Implementing artificial intelligence to risk stratify, manage and refer patients
Dr Mike Fisher highlights the clinical impact of more-intensive vs. less-intensive LDL-C lowering and the reduction in major vascular events, then discusses how good we are at lowering LDL-C in clinical practice, and presents a solution in a new project implementing artificial intelligence to risk stratify, manage and refer patients in cardiac rehabilitation.
Keep in touch with Sanofi to make sure your don't miss out on the latest educational materials for you and your patients.